Artal Group S.A. - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 126 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$10,005,000
+46.6%
850,000
+70.0%
0.40%
+45.2%
Q1 2019$6,825,000
+232.9%
500,000
+150.0%
0.28%
+267.1%
Q4 2018$2,050,000
-64.2%
200,000
-60.0%
0.08%
-11.6%
Q4 2017$5,725,000
-6.5%
500,0000.0%0.09%
-18.9%
Q3 2017$6,125,000
+78.3%
500,000
+66.7%
0.11%
+76.7%
Q2 2017$3,435,000
-45.0%
300,0000.0%0.06%
-56.8%
Q1 2017$6,240,000300,0000.14%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Novo Holdings A/S 3,201,183$40,591,0003.96%
Cormorant Asset Management, LP 150,000$1,902,0000.39%
PFM Health Sciences, LP 1,034,030$13,112,0000.30%
Partner Investment Management, L.P. 23,660$300,0000.11%
PointState Capital LP 375,000$4,755,0000.09%
Spark Investment Management LLC 38,400$486,0000.07%
SECTORAL ASSET MANAGEMENT INC 89,300$1,132,0000.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 95,722$1,214,0000.05%
CADIAN CAPITAL MANAGEMENT, LP 120,000$1,522,0000.04%
Nicholas Investment Partners, LP 49,341$626,0000.04%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders